Prevalence and Characteristics of Venous Thrombosis After Catheter Ablation of Atrial Fibrillation in Patients Receiving Periprocedural Direct Oral Anticoagulants

Overview

Journal J Atr Fibrillation

Date 2019 May 30

PMID 31139285

Authors

Takehito Sasaki

Kohki Nakamura

Kentaro Minami

Yutaka Take

Keiko Koyama

Eiji Yamashita

Shigeto Naito

Affiliations

Soon will be listed here.

Abstract

Background: Periprocedural venous thromboembolisms (VTEs) area rare occurrence but a critical complication after catheter ablation of atrial fibrillation (AF).The aim of this study was to investigate the incidence of symptomatic deep vein thromboses (DVTs) and pulmonary thromboembolisms (PTEs) in patients who underwent AF catheter ablation and received periprocedural oral anticoagulation with direct oral anticoagulants (DOACs).

Methods And Results: A total of 2,193 consecutive patients undergoing AF catheter ablation with periprocedural DOACs were retrospectively analyzed.Two patients (0.091%) experienced symptomatic DVTs after the ablation, and no patients had any PTEs. One patient was a 72-year-old female who underwent cryoballoon ablation with periprocedural apixaban at a dose of 2.5 mg twice daily. The other patient was a 74-year-old male who underwent a Hot Balloon ablation and thereafter radiofrequency catheter ablation for recurrent AF with edoxaban at30 mg once daily. Both DVT patients underwent AF ablation by the right femoral vein approach, and after discharge had right leg pain and swelling on post-procedural days 4 and 8, respectively. TheDVT was treated by increasing the dose of apixaban and changing it from 30 mg/day of edoxaban to 15-30 mg/day of rivaroxaban, and the thrombi completely disappeared in both patients without any thromboembolic and hemorrhagic complications.

Conclusions: AF catheter ablation with periprocedural DOAC treatment revealed anextremely low incidence of symptomatic VTEs, which may be successfully treated by increasing the DOAC dose or changing the DOAC type.

References

Kroegel C, Reissig A . Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration. 2003; 70(1):7-30. DOI: 10.1159/000068427. View

Calkins H, Brugada J, Packer D, Cappato R, Chen S, Crijns H . HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical.... Europace. 2007; 9(6):335-79. DOI: 10.1093/europace/eum120. View

Prudente L, Moorman J, Lake D, Xiao Y, Greebaum H, Mangrum J . Femoral vascular complications following catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2009; 26(1):59-64. DOI: 10.1007/s10840-009-9402-y. View

Cappato R, Calkins H, Chen S, Davies W, Iesaka Y, Kalman J . Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2009; 53(19):1798-803. DOI: 10.1016/j.jacc.2009.02.022. View

Dagres N, Hindricks G, Kottkamp H, Sommer P, Gaspar T, Bode K . Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern?. J Cardiovasc Electrophysiol. 2009; 20(9):1014-9. DOI: 10.1111/j.1540-8167.2009.01493.x. View

Cappato R, Calkins H, Chen S, Davies W, Iesaka Y, Kalman J . Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2009; 3(1):32-8. DOI: 10.1161/CIRCEP.109.859116. View

Baman T, Jongnarangsin K, Chugh A, Suwanagool A, Guiot A, Madenci A . Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011; 22(6):626-31. PMC: 3471534. DOI: 10.1111/j.1540-8167.2010.01995.x. View

Bohnen M, Stevenson W, Tedrow U, Michaud G, John R, Epstein L . Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm. 2011; 8(11):1661-6. DOI: 10.1016/j.hrthm.2011.05.017. View

Saad E, dAvila A, Costa I, Aryana A, Slater C, Costa R . Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study. Circ Arrhythm Electrophysiol. 2011; 4(5):615-21. DOI: 10.1161/CIRCEP.111.963231. View

10.

Hung C, Lin T, Hsieh Y, Lee W, Huang J, Chang W . Acute massive pulmonary embolism after radiofrequency catheter ablation: a rare complication after a common procedure. J Chin Med Assoc. 2012; 75(8):409-12. DOI: 10.1016/j.jcma.2011.07.002. View

11.

Moubarak G, Bonhomme S, Vedrenne G, Bouleti C, Ollitrault J, Priollet P . Femoral vein thrombosis after right-sided electrophysiological procedures. J Interv Card Electrophysiol. 2013; 38(3):155-8. DOI: 10.1007/s10840-013-9832-4. View

12.

Winkle R, Hardwin Mead R, Engel G, Kong M, Patrawala R . Atrial fibrillation ablation using open-irrigated tip radiofrequency: experience with intraprocedural activated clotting times ≤210 seconds. Heart Rhythm. 2014; 11(6):963-8. DOI: 10.1016/j.hrthm.2014.03.013. View

13.

Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan G . Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm.... Europace. 2015; 17(8):1197-214. DOI: 10.1093/europace/euv190. View

14.

Yang G, De Staercke C, Hooper W . The effects of obesity on venous thromboembolism: A review. Open J Prev Med. 2015; 2(4):499-509. PMC: 4520798. DOI: 10.4236/ojpm.2012.24069. View

15.

Traulle S, Kubala M, Doucy A, Quenum S, Hermida J . Feasibility and safety of temporary subcutaneous venous figure-of-eight suture to achieve haemostasis after ablation of atrial fibrillation. Europace. 2015; 18(6):815-9. DOI: 10.1093/europace/euv266. View

16.

Ho K, Bham E, Pavey W . Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2015; 4(10):e002652. PMC: 4845147. DOI: 10.1161/JAHA.115.002652. View

17.

Aytemir K, Canpolat U, Yorgun H, Evranos B, Kaya E, Sahiner M . Usefulness of 'figure-of-eight' suture to achieve haemostasis after removal of 15-French calibre femoral venous sheath in patients undergoing cryoablation. Europace. 2015; 18(10):1545-1550. DOI: 10.1093/europace/euv375. View

18.

Nakamura K, Naito S, Sasaki T, Minami K, Take Y, Goto E . Silent Cerebral Ischemic Lesions After Catheter Ablation of Atrial Fibrillation in Patients on 5 Types of Periprocedural Oral Anticoagulation　- Predictors of Diffusion-Weighted Imaging-Positive Lesions and Follow-up Magnetic Resonance Imaging. Circ J. 2016; 80(4):870-7. DOI: 10.1253/circj.CJ-15-1368. View

19.

Huisman M, Rothman K, Paquette M, Teutsch C, Diener H, Dubner S . The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2. J Am Coll Cardiol. 2017; 69(7):777-785. DOI: 10.1016/j.jacc.2016.11.061. View

20.

Marzec L, Wang J, Shah N, Chan P, Ting H, Gosch K . Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation. J Am Coll Cardiol. 2017; 69(20):2475-2484. DOI: 10.1016/j.jacc.2017.03.540. View